Location History:
- Köln, DE (2012 - 2020)
- Cologne, DE (2017 - 2021)
Company Filing History:
11 out of 721 
5 out of 378 
1 out of 197 
Years Active: 2012-2021
Title: Innovator in Antibody Development - Andreas Wilmen
Introduction
Andreas Wilmen, an accomplished inventor based in Köln, Germany, has made significant contributions to the field of biotechnology with a remarkable portfolio of 17 patents. His innovative work primarily focuses on the development of humanized monoclonal antibodies that address critical challenges in coagulation and thrombosis.
Latest Patents
One of his most recent patents is titled "Epitope of optimized humanized monoclonal antibodies against activated protein C and uses thereof." This invention provides optimized humanized antibodies that selectively bind to and inhibit activated protein C without affecting its unactivated counterpart. The antibodies specifically target distinct epitopes beyond the catalytic triad of human activated protein C, offering promising treatment methods.
Another notable patent from Andreas Wilmen is centered around "Antibodies capable of binding to the coagulation factor XIa and uses thereof." This invention focuses on creating antibodies that can bind to coagulation factor XI and its activated form, factor XIa. The methods of using these antibodies aim to inhibit platelet aggregation, which is crucial in preventing thrombus formation.
Career Highlights
Andreas has worked with prominent organizations, including Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. His expertise in the field has contributed to advancements in therapeutic applications of monoclonal antibodies.
Collaborations
Throughout his career, he has collaborated with notable colleagues such as Christoph Freiberg and Stephan Siegel. These partnerships have fostered innovation and research in antibody development, enhancing the potential impact of their inventions.
Conclusion
Andreas Wilmen's work exemplifies the intersection of innovative thinking and practical applications in biotechnology. His significant contributions continue to pave the way for advancements in medical treatment, particularly in the realm of coagulation disorders. With his impressive portfolio of patents, he remains a key figure in the research and development of monoclonal antibodies, driving progress in the healthcare sector.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.